C2N Diagnostics, LLC Company Profile

23:41 EDT 24th March 2018 | BioPortfolio

C2N Diagnostics, LLC ( formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, the Washington University Office of Technology Management, and LifeTech Research, a Maryland-based technology research and commercialization firm ( C2N is commercializing a suite of novel biomarker assays and tools to assist in pre-clinical drug discovery, clinical drug development, and the early detection and assessment of progression of debilitating neurodegenerative disorders. The company’s products include the SILK-Aβ®, SISAQ-Aβ™, and SISAQ-Tau™ Assays, which rely upon stable isotope labeling and tandem mass spectrometry for the measurement of the kinetics, or in vivo metabolism, and absolute quantitation of brain derived proteins. Beyond AD, products are in development to target Parkinson’s disease, Huntington’s disease, brain injury, schizophrenia, and amyotrophic lateral sclerosis (ALS), among others. For additional information, please contact or call 1-877-C2N-DIAG (1-877-226-3424).

News Articles [409 Associated News Articles listed on BioPortfolio]

Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay

Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB)...

German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s

Hummingbird Diagnostics has teamed up with Saarland University to develop molecular diagnostics that can detect serious diseases early using blood samples.  Based in Heidelberg, Germany, Hummingbird ...

Carbapenemase Diagnostics Market 20172022: Test Volume and Sales Forecasts by CountryUS, Europe, Japan [Report Updated: 15012018] Prices from USD $950

This report presents test volumes and sale forecasts for the US, Europe France, Germany, Italy, Spain, UK and Japan. List of TablesFrance Carbapenemase Test Volume and Diagnostics Sales ForecastGerma...

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF Diagnostics

EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body Now Available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System....

BNP Test Volume and Sales Forecasts 20172022: US, Europe, Japan [Report Updated: 15012018] Prices from USD $750

This new report from VPGMarketResearch provides analysis of BNP testing, including test volume and sales forecasts by country. Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USAList of T...

DOD taps Ortho Clinical Diagnostics for $9.8M surgical products contract

In-vitro diagnostics company Ortho Clinical Diagnostics was awarded a contract worth up to approximately $9.8 million from th -More- 

2021 Hepatitis Diagnostics Market: USA, Europe, JapanSupplier Shares, Test Volume and Sales Forecasts by Country and Market SegmentHospitals, Blood Banks, Commercial and Public Health Labs, POC Locations [Report Updated: 23102017] Prices from USD $3850

This report presents test volumes, sale forecasts and supplier shares for the US, Europe France, Germany, Italy, Spain, UK and Japan. The report provides test volume and sales forecasts for HAV NAT, H...

Quotidian Technical Highlights on Selected Medical Equipment Stocks -- GenMark Diagnostics, ... GenMark Diagnostics Carlsbad, Californiaheadquartered GenMark Diagnostics Inc.'s shares recorded a trading volume of 333,899 shares last Friday. The stock finis...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [224 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

The importance of medical imaging in the diagnosis and monitoring of cancer cannot be overstated. As personalized cancer treatments are gaining popularity, a need for more advanced imaging techniques ...

A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.

To assess a new and highly specific, but low-cost, easily performed and suitable for large-scale applications method for renal fibrosis (RF) diagnostics.

Nucleic acid diagnostic approaches in parasitology.

Nucleic acid diagnostic technologies are partly replacing traditional microscopy and antigen detection methods in parasitological diagnostics. In particular, the diagnostics of parasitic diarrhea is u...

Local enamel demineralization diagnostics and treatment.

The article describes focal enamel demineralization - the most common disease of teeth hard tissues. Local and general factors of this pathological process advent and development were described. The m...

Clinical Trials [185 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Companies [912 Associated Companies listed on BioPortfolio]

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics ( develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (, headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distrib...

More Information about "C2N Diagnostics, LLC" on BioPortfolio

We have published hundreds of C2N Diagnostics, LLC news stories on BioPortfolio along with dozens of C2N Diagnostics, LLC Clinical Trials and PubMed Articles about C2N Diagnostics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of C2N Diagnostics, LLC Companies in our database. You can also find out about relevant C2N Diagnostics, LLC Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record